SCHEMBL24908522

SCHEMBL24908522

CCc1ccc(C(F)(F)F)cc1C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
HPGD P15428 3/20 0.54
KDM4E B2RXH2 2/20 0.54
HSD17B10 Q99714 2/20 0.54
USP2 O75604 1/20 0.51
CYP2C19 P33261 1/20 0.51
MRGPRX4 Q96LA9 2/20 0.49
LIPG Q9Y5X9 3/20 0.49
LIPC P11150 2/20 0.49
CES2 O00748 2/20 0.49
SORT1 Q99523 7/20 0.47
PLK1 P53350 1/20 0.46
TAS2R14 Q9NYV8 1/20 0.46
MEN1 O00255 1/20 0.44
CYP1A2 P05177 1/20 0.44
ALOX12 P18054 1/20 0.44
KMT2A Q03164 1/20 0.44
RXRA P19793 1/20 0.44
RXRB P28702 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL7105697 0.87 ALDH1A1 (0.49) ALDH1A1HPGDKDM4EHSD17B10USP2
SCHEMBL8477461 0.86 ALDH1A1 (0.54) ALDH1A1HPGDKDM4EHSD17B10USP2
SCHEMBL421582 0.86 ALDH1A1 (0.59) ALDH1A1HPGDKDM4EHSD17B10USP2
SCHEMBL24720949 0.86 JAK2 (0.50) ALDH1A1HPGDKDM4EHSD17B10USP2
SCHEMBL8477458 0.86 ALDH1A1 (0.54) ALDH1A1HPGDKDM4EHSD17B10USP2
Ammonia Solution, Strong SCHEMBL7107044 0.84 PLK1 (0.52) ALDH1A1HPGDKDM4EHSD17B10USP2
SCHEMBL2337724 0.84 ALDH1A1 (0.53) ALDH1A1HPGDKDM4EHSD17B10USP2
SCHEMBL6993058 0.84 ALDH1A1 (0.57) ALDH1A1HPGDKDM4EHSD17B10USP2
SCHEMBL16952454 0.84 CES2 (0.46) ALDH1A1HPGDKDM4EHSD17B10USP2
SCHEMBL477593 0.83 KDM4E (0.50) ALDH1A1HPGDKDM4EHSD17B10USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230014445-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE LOXO ONCOLOGY, INC. 2023-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230014445-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE PIK3CA, PIK3R4, PIK3R5 ALDH1A1 3272/4885HPGD 2892/4885KDM4E 2710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.